Rapid disappearance of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia following bone marrow transplantation and chemotherapy.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Leukemia and Lymphoma

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10428199709109169PMID 9250799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disappearance of AML1 ‐MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long‐term remission

  1995cited by this paper
• Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.

  1994cited by this paper
• Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL).

  1994cited by this paper
• AML-1 gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21).

  1994cited by this paper
• Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.

  1994cited by this paper
• Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.

  1994cited by this paper
• AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.

  1994cited by this paper
• The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1.

  1993cited by this paper
• Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission.

  1993cited by this paper
• An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation.

  1993cited by this paper
• Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission.

  1993cited by this paper
• Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia.

  1993cited by this paper
• Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.

  1993cited by this paper
• Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia.

  1993cited by this paper
• Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients.

  1993cited by this paper
• Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long- term remission

  1993cited by this paper
• Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients

  1993cited by this paper
• The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1

  1993cited by this paper
• Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

  1992cited by this paper
• Genotypic Typing Using Amplified Variable Number of Tandem Repeats with Polymerase Chain Reaction Following Allogeneic Bone Marrow Transplantation.

  1992cited by this paper
• Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation

  1992cited by this paper
• Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation.

  1992cited by this paper
• t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

  1991cited by this paper
• The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus

  1990cited by this paper
• A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

  1990cited by this paper
• Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.

  1990cited by this paper
• The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.

  1985cited by this paper
• 8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features

  1984cited by this paper

• Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)

  2013cites this paper
• Clinical significance of minimal residual disease in childhood acute myeloid leukemia

  2004cites this paper
• Detection of Minimal Residual Disease in Acute Myelogenous Leukemia

  2004cites this paper
• Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

  2003cites this paper
• Minimal Residual Disease in Acute Myeloid Leukemia

  2002cites this paper
• Studies on the core binding factor complex in patients with acute myeloid leukaemia.

  2002cites this paper
• AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML

  2001cites this paper
• Minimal residual disease in acute promyelocytic leukemia.

  2000cites this paper
• The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease

  2000cites this paper
• 小児白血病における微少残存腫瘍 (MRD) の臨床的意義

  1999cites this paper